SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Schiehalli. Regulatory News (MNTN)

Share Price Information for The Schiehalli. (MNTN)

Share Price is delayed by 15 minutes
Get Live Data
2.17    0.02 (0.93%)
Bid:
2.18
Ask:
2.20
Spread: 0.02 (0.917%)
Market Cap: $2.23b
MNTN Live PriceLast checked at - London Stock Exchange

Intraday The Schiehalli. Share Chart

C Share Conversion Ratio

7 Sep 2023 12:25

RNS Number : 7522L
Schiehallion Fund Limited (The)
07 September 2023
 

The Schiehallion Fund Limited

(the "Company")

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

C Share Conversion Ratio

Further to the announcement on 3 August 2023, the Company is pleased to announce the Conversion Ratio on the basis of the respective Net Asset Values of the Ordinary Shares and the C Shares as at the Conversion Calculation Date, being 31 August 2023.

 

 

Net Asset Value per Ordinary Share

106.14 cents

Net Asset Value per C Share

80.68 cents

Conversion Ratio

0.7601 Ordinary shares for each C Share

 

 

The number of New Ordinary Shares to be issued as a result of Conversion will be calculated based on the register at 6.00 p.m. on 8 September 2023 and is expected to be announced on 11 September 2023. The holders of C Shares will not be entitled to fractions of New Ordinary Shares arising on Conversion. Instead, the number of New Ordinary Shares to be issued to each holder will be rounded down to the nearest whole number of Ordinary Shares and fractional entitlements will be disregarded, with any value attributable to them being retained for the benefit of the Company. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares, including the right to receive all future dividends or distributions declared in respect of the Ordinary Shares.

 

Application has been made for the New Ordinary Shares to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market ("Admission"). It is now expected that admission will become effective and that dealings in the New Ordinary Shares will commence at 8:00 a.m. on 12 September 2023 (rather than 11 September 2023, as indicated in the announcement on 3 August 2023).

 

Application will also be made to cancel the C Shares from trading on the London Stock Exchange as soon as reasonably practicable following Conversion.

 

 

 

Expected timetable

 

Event

Date

Conversion record date

6:00 p.m. on 8 September 2023

Cancellation of C Shares

As soon as reasonably practicable following conversion

Admission of new Ordinary Shares on Conversion and dealings commence

 

8:00 a.m. on 12 September 2023

Crediting of CREST accounts with new Ordinary Shares

12 September 2023

Share Certificates in respect of new Ordinary Shares despatched

w/c 18 September 2023

 

 

Capitalised terms used but not defined in this announcement will have the same meaning as set out in the Prospectus.

 

 

 

 

Baillie Gifford & Co Limited

7 September 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBUAROUUKRAR
Date   Source Headline
3rd Oct 20244:54 pmRNSTransaction in Own Shares
1st Oct 20242:01 pmRNSNet Asset Value(s)
1st Oct 202410:28 amRNSTotal Voting Rights
26th Sep 202411:19 amRNSHalf-year Report
24th Sep 202412:45 pmRNSTransaction in Own Shares
20th Sep 20244:20 pmRNSTransaction in Own Shares
13th Sep 20247:00 amRNSThe Schiehallion Fund Interim Report to 31/07/24
12th Sep 20244:17 pmRNSTransaction in Own Shares
2nd Sep 20245:13 pmRNSTransaction in Own Shares
2nd Sep 20242:10 pmRNSNet Asset Value(s)
20th Aug 202412:39 pmRNSNet Asset Value(s)
6th Aug 20244:27 pmRNSNet Asset Value(s)
6th Aug 202411:46 amRNSNet Asset Value(s)
1st Aug 20242:53 pmRNSClosed Period Confirmation
1st Aug 20242:48 pmRNSNet Asset Value(s)
1st Jul 20243:11 pmRNSNet Asset Value(s)
3rd Jun 20243:03 pmRNSNet Asset Value(s)
3rd Jun 202411:37 amRNSTotal Voting Rights
29th May 20244:31 pmRNSTransaction in Own Shares
21st May 20244:27 pmRNSTransaction in Own Shares
13th May 202410:41 amRNSResult of AGM
1st May 20244:36 pmRNSNet Asset Value(s)
1st May 202410:36 amRNSTotal Voting Rights
30th Apr 20244:31 pmRNSTransaction in Own Shares
29th Apr 202410:56 amRNSBlock listing Interim Review
23rd Apr 20243:05 pmRNSBoard Update
18th Apr 20242:32 pmRNSTransaction in Own Shares
16th Apr 20244:36 pmRNSTransaction in Own Shares
8th Apr 20244:13 pmRNSAnnual Financial Report
4th Apr 20247:00 amRNSThe Schiehallion Fund Limited Annual Results
2nd Apr 20244:35 pmRNSNet Asset Value(s)
2nd Apr 202412:25 pmRNSTotal Voting Rights
11th Mar 20244:58 pmRNSTransaction in Own Shares
1st Mar 20245:07 pmRNSTransaction in Own Shares
1st Mar 20243:01 pmRNSNet Asset Value(s)
1st Mar 202411:17 amRNSTotal Voting Rights
28th Feb 20245:03 pmRNSTransaction in Own Shares
27th Feb 20244:54 pmRNSTransaction in Own Shares
22nd Feb 20244:45 pmRNSTransaction in Own Shares
13th Feb 20244:53 pmRNSTransaction in Own Shares
5th Feb 20244:36 pmRNSTransaction in Own Shares
1st Feb 20243:05 pmRNSClosed Period Confirmation
1st Feb 20242:00 pmRNSNet Asset Value(s)
1st Feb 202411:17 amRNSTotal Voting Rights
26th Jan 20245:13 pmRNSTransaction in Own Shares
16th Jan 202412:48 pmRNSTransaction in Own Shares
4th Jan 20243:22 pmRNSTransaction in Own Shares
3rd Jan 20243:55 pmRNSTotal Voting Rights
20th Dec 20231:28 pmRNSNet Asset Value(s)
7th Dec 20234:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.